IPOPLUS

₹1.92

▲ +0.22 +12.94%

16 Jun 2026

BSE Listed

Vivanza Biosciences Limited (530057)

Volume: 57,411Avg Vol 1W: 25,792Avg Vol 1M: 23,29252W Range:₹3₹9.54
BSE
Key Ratios
Updated 1h ago
Market Cap₹20 Cr
Current Price₹1.92
Previous Close₹1.7
High / Low (52w)₹9.54 / ₹3
Volume57,411
Avg Vol (1W)25,792
Avg Vol (1M)23,292
Stock P/E246.5
Book Value₹1.22
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B4.03
Debt / Equity—
50 DMA₹1.9
200 DMA₹2.04
Day change+12.94%
Price Chart
₹1.92▼ 10.70% · 1Y
₹3₹24.5L
2025-06-18
2026-06-16

20-day avg volume: 24K shares

Pros
  • Revenue grew 1461% YoY.
Cons
  • Stock trades at a high P/E of 247.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Sep 2024
Revenue₹6 Cr₹45 Cr₹55 Cr₹9 Cr₹0 Cr—
EBITDA₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹-1 Cr—
Net Profit₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹-1 Cr—
EPS-0.110.050.140.02-0.25—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹116 Cr₹7 Cr₹28 Cr₹18 Cr—
EBITDA₹1 Cr₹0 Cr₹1 Cr₹1 Cr—
Net Profit₹0 Cr₹-1 Cr₹1 Cr₹1 Cr—
EPS—-0.170.010.150.08
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹22 Cr₹16 Cr₹20 Cr₹22 Cr—
Total Liabilities₹18 Cr₹12 Cr₹15 Cr₹18 Cr—
Equity₹4 Cr₹4 Cr₹5 Cr₹4 Cr—
Total Debt₹10 Cr₹9 Cr₹5 Cr₹8 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹-3 Cr₹-2 Cr₹2 Cr₹-1 Cr—
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr—
Financing₹3 Cr₹2 Cr₹-2 Cr₹1 Cr—
Free Cash Flow₹-3 Cr₹-3 Cr₹2 Cr₹-1 Cr—

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search